Literature DB >> 7795719

Adenosine: a new agent in the diagnosis of impotence.

S Kiliç1, M Salih, K Anafarta, S Baltaci, A Koşar.   

Abstract

The haemodynamic effects of different dosages of adenosine were studied using colour flow Doppler sonography (CFDS) in 33 men, whose penile vascular bed responded well to papaverine. In six cases, we injected 25, 50, 100, 250 micrograms dosages of adenosine intracavernously at 15 min intervals and no erection occurred. However, 500 and 1000 micrograms doses of adenosine increased the arterial blood velocities for a few seconds in five cases. Later on, in eight cases, we infused 80 and 120 micrograms/kg/min adenosine for 3 min and only with 120 micrograms/kg/min dosage, did we observe clinical response and significant changes in CFDS parameters. Finally, 120 micrograms/kg/min adenosine dosage was infused for 10 min in 14 men and eight showed full erection while six had only tumescence. As adenosine was rapidly metabolized by adenosine deaminase, the erection lasted for only 5 to 13 min. No prolonged erection and no other side-effect was observed. In addition no fibrosis and curvature was detected 6 months after the injections. We found that, in men, 10 min infusion of 120 micrograms/kg/min adenosine increased the arterial flow and to some extent venous resistance, resulting in full erection or tumescence. Therefore, adenosine may be used as an agent for the diagnosis of vasculogenic impotence, but further studies for determining the standard dosage of adenosine are needed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7795719

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  9 in total

Review 1.  Role of adenosine signaling in penile erection and erectile disorders.

Authors:  Prasad V Phatarpekar; Jiaming Wen; Yang Xia
Journal:  J Sex Med       Date:  2010-11       Impact factor: 3.802

2.  A2B adenosine receptor contributes to penile erection via PI3K/AKT signaling cascade-mediated eNOS activation.

Authors:  Jiaming Wen; Almut Grenz; Yujin Zhang; Yingbo Dai; Rodney E Kellems; Michael R Blackburn; Holger K Eltzschig; Yang Xia
Journal:  FASEB J       Date:  2011-05-12       Impact factor: 5.191

3.  Role of Adenosine Receptor(s) in the Control of Vascular Tone in the Mouse Pudendal Artery.

Authors:  Hicham Labazi; Stephen L Tilley; Catherine Ledent; S Jamal Mustafa
Journal:  J Pharmacol Exp Ther       Date:  2015-12-30       Impact factor: 4.030

Review 4.  Adenosine signaling in normal and sickle erythrocytes and beyond.

Authors:  Yujin Zhang; Yang Xia
Journal:  Microbes Infect       Date:  2012-05-23       Impact factor: 2.700

5.  Impaired erectile function in CD73-deficient mice with reduced endogenous penile adenosine production.

Authors:  Jiaming Wen; Yingbo Dai; Yujin Zhang; Weiru Zhang; Rodney E Kellems; Yang Xia
Journal:  J Sex Med       Date:  2011-05-19       Impact factor: 3.802

6.  Excess adenosine in murine penile erectile tissues contributes to priapism via A2B adenosine receptor signaling.

Authors:  Tiejuan Mi; Shahrzad Abbasi; Hong Zhang; Karen Uray; Janci L Chunn; Ling Wei Xia; Jose G Molina; Norman W Weisbrodt; Rodney E Kellems; Michael R Blackburn; Yang Xia
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

7.  Adenosine deaminase enzyme therapy prevents and reverses the heightened cavernosal relaxation in priapism.

Authors:  Jiaming Wen; Xianzhen Jiang; Yingbo Dai; Yujin Zhang; Yuxin Tang; Hong Sun; Tiejuan Mi; Rodney E Kellems; Michael R Blackburn; Yang Xia
Journal:  J Sex Med       Date:  2010-09       Impact factor: 3.802

8.  Adenosine actions are preserved in corpus cavernosum from obese and type II diabetic db/db mouse.

Authors:  Fernando Silva Carneiro; Fernanda R C Giachini; Victor V Lima; Zidonia N Carneiro; Romulo Leite; Edward W Inscho; Rita C Tostes; R Clinton Webb
Journal:  J Sex Med       Date:  2008-01-21       Impact factor: 3.802

9.  Dipyridamole reduces penile apoptosis in a rat model of post-prostatectomy erectile dysfunction.

Authors:  Omer Kutlu; Ersagun Karaguzel; Ali Ertan Okatan; Ahmet Mentese; Esin Yulug; Ilke Onur Kazaz; Selcuk Kutlu; Eyup Dil; Huseyin Eren; Ahmet Alver
Journal:  Int Braz J Urol       Date:  2017 Sep-Oct       Impact factor: 1.541

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.